This multi-cohort study delineates developmental trajectories of psychopathic features across childhood and adolescence (ages 7–16) and investigates associations with adult outcomes (ages~23–34). Although most youth demonstrated consistently low levels of psychopathic features, approximately 10%−15% followed a chronically high trajectory. A similar number (~14%) displayed initially high levels that decreased over time, while others (~10%−20%) followed an increasing pattern. Boys in the chronically high trajectory exhibited the most deleterious adult outcomes and some evidence suggested that youth in the decreasing subgroup experienced fewer maladaptive outcomes than those in the increasing and high groups. Findings revealed substantial malleability in the developmental course of psychopathic features and suggest that unique pathways may exert considerable influence on future engagement in antisocial and criminal behaviors.
In contrast to the extensive literature based on mock jurors, large-sample studies of decision making by real juries are relatively rare. In this field study, we examined relationships between jury verdicts and variables representing 3 classes of potential determinants-evidentiary, extraevidentiary, and deliberation process-using a sample of 114 criminal jury trials. Posttrial data were collected from 11 presiding judges, 31 attorneys, and 367 jurors using a Web-based questionnaire. The strength of the prosecution's evidence was strongly related to the occurrence of a conviction, whereas most extraevidentiary and deliberation process variables were only weakly to modestly related in bivariate form and when the prosecution's evidence strength was controlled. Notable exceptions to this pattern were jury demographic diversity as represented by the number of different race-gender subgroups (e.g., Black males) present in the jury, and several deliberation process variables reflecting advocacy for acquittal (e.g., presence of an identifiable proacquittal faction within the jury and proacquittal advocacy by the foreperson). Variables reflecting advocacy for conviction were essentially unrelated to jury verdict. Sets of extraevidentiary and deliberation variables were each able to modestly improve the explanation of jury verdicts over prosecution evidence strength in multivariate models. This study highlights the predictive efficacy of prosecution evidence strength with respect to jury verdicts, as well as the potential importance of jury demographic diversity and advocacy for acquittal during deliberation.
The scientist–practitioner model of training in industrial and organizational psychology provides the foundation for the education of industrial and organizational psychologists across the world. This approach is important because, as industrial and organizational psychologists, we are responsible for both the creation and discovery of knowledge and the use or application of that knowledge. In multiple articles recently published in this journal, Pulakos and her colleagues (Pulakos, Mueller Hanson, Arad, & Moye, 2015; Pulakos & O’Leary, 2011) have argued that performance management (PM), as applied and implemented in organizations, is broken. This is not a unique take on the state of PM in organizations, as others have been arguing for many years that PM is no longer working in organizations the way that we would like it to work (Banks & Murphy, 1985; Bretz, Milkovich, & Read, 1992). Further, for many years and in many Society for Industrial and Organizational Psychology conference panels and debates in the literature, we have been inundated with discussions and conversations around the science–practice gap and around the gap being especially evident in PM.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.